Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 626-650 of 958 matching filings.

Per page
25
Current page
26
4

LOAR

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

DIETZ

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SINGH

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KOLLINS

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OCLASSEN

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PATTERSON

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KILEY

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36066

DEF 14A

Filing date
27 May 2014
Reporting date
27 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
16 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
PREC14A File 001-36066

PREC14A

Filing date
12 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
05 May 2014
Reporting date
05 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-194624

FORM S-8

Filing date
17 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
13 Mar 2014
Reporting date
13 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36066

FORM 8-K/A

Filing date
05 Mar 2014
Reporting date
13 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81821

SCHEDULE 13G/A 2-4-14

Filing date
04 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
14 Jan 2014
Reporting date
13 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
02 Jan 2014
Reporting date
02 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
20 Dec 2013
Reporting date
20 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
20 Dec 2013
Reporting date
19 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81821

SCHEDULE 13G 12-18-13

Filing date
18 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
17 Dec 2013
Reporting date
17 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36066

FORM 8-K

Filing date
17 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .